SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-136147
Filing Date
2024-05-10
Accepted
2024-05-10 16:06:05
Documents
13
Period of Report
2024-05-09
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d835180d8k.htm   iXBRL 8-K 23335
  Complete submission text file 0001193125-24-136147.txt   142237

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA me-20240509.xsd EX-101.SCH 2845
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE me-20240509_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE me-20240509_pre.xml EX-101.PRE 10811
17 EXTRACTED XBRL INSTANCE DOCUMENT d835180d8k_htm.xml XML 3556
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-39587 | Film No.: 24934820
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)